Erectile dysfunction (ED) is defined as the noesis to attain or maintain an adequate penile sexual arousal for satisfactory sexual sexual relation. Since the movement into clinical recitation of viagra (sildenafil; Pfizer Pharmaceutical Corp.; New York, NY), there has been a dramatic upshot in the handling algorithm for men with ED.
No longer do all men agony from ED have to resource to the surgical positioning of a penile prosthesis, intracavernosal injections or transurethral insertions of vasoactive agents, or vacancy tumescence devices in gild to sketch sexual relations.
Numerous placebo-controlled clinical ED studies lasting less than 1 year have documented the condition and efficacy of sildenafil in patients with ED of various etiologies.
An unanswered proposal of marriage in honour to long-term viagra use is that of tachyphylaxis, a pharmacokinetic appendage in which paper sensitiveness to a drug diminishes.
A corresponding holograph by El-Galley and colleagues published in 2001 reported that viagra produced tachyphylaxis, since 20% of the patients who were followed for 2 eld needed increased dosages and 17% discontinued tending because of the eventual lack of efficacy.
The results of the El-Galley report were largely discounted upon poor follow-up; 50% of the men on viagra did not respond to a electronic equipment interrogatory at 2 years’ follow-up.
In range, a 3-year follow-up engrossment in nerve-sparing free radical prostatectomy patients (n = 41) revealed that 71% (29/41) were apparatus responding to the same dose of viagra . Of the 29% of dropouts, half (6/12) stopped because of legal document of spontaneous erections, with only 5 of 12 gradually losing efficacy.
Hence, most authorities have attributed loss of viagra efficacy not to tachyphylaxis, but to movement in organic disease from associated comorbidities and ripening.
However, a recent acquisition using cultured rat cavernosal smooth ruffian cells demonstrated molecular upregulation of the phosphodiesterase type 5 (PDE-5) enzyme when the cells treated with high doses of sildenafil for at least 7 days. These findings suggest that sildenafil is safe and effective when used at normal clinical doses and recommended dosing frequencies.
However, additional clinical inquiry will be needed to evaluate the tachyphylaxis symptom in chronic PDE-5 inhibitor use, especially when these agents possess long half-lives.